Centro de Histoterapia Placentaria "Dr. Carlos Manuel Miyares Cao", 35 años de entrega a la Ciencia Cubana / "Dr. Carlos Miyares Cao" Placental Histotherapy Center, 35 years of dedication to Cuban Science

Introducción: La fundación del Centro de Histoterapia Placentaria, el 25 de abril de 1986, como resultado de la repercusión internacional por el nuevo método cubano del tratamiento del vitiligo con un medicamento obtenido de la placenta humana, descubierto por el doctor Carlos Manuel Miyares Cao, favoreció el desarrollo de las Ciencias Médicas en Cuba. Institución de prestigio, que arribó este 2021 a su Aniversario 35, y que ha obtenido un gran impacto en la salud y calidad de vida de personas con enfermedades dermatológicas como vitiligo, psoriasis y alopecia. Objetivo: Conocedores de la importancia de salvaguardar los hitos históricos como elementos imprescindibles en la trayectoria científico-social de una institución, nos propusimos exponer los componentes fundamentales que conforman este Centro de Histoterapia Placentaria e incentivar a las nuevas generaciones para continuar la labor investigativa que realiza este y la necesidad de preservar su historia. Material y Métodos: Se realizó una investigación histórico-bibliográfica de los documentos compilados que se conservan en la Biblioteca del Centro para poder fundamentar este artículo. Desarrollo: Se incluyen los aspectos esenciales que avalan la historia del Centro y la imbricación científico-social-humana en este del Dr. Carlos Manuel Miyares Cao. Conclusiones: Históricamente ofrecer toda la trayectoria de este Centro de Histoterapia Placentaria y su significación e importancia para la Ciencia Cubana, así como transmitir a especialistas, médicos y, en general, trabajadores de la salud, su destacada labor en la recuperación de graves enfermedades que aquejan a la población mundial(AU)

Introduction: As a result of the international repercussion of a new Cuban method for treating vitiligo with a drug obtained from human placenta, discovered by Dr. Carlos Manuel Miyares Cao, the Placental Histotherapy Center was founded on April 25, 1986 to support the development of Medical Sciences in Cuba. This prestigious institution, which arrived to its 35th Anniversary this year, has made a significant impact on the health and quality of life of people with dermatological diseases such as vitiligo, psoriasis and alopecia. Objective: Knowing the importance of safeguarding historical milestones as essential elements in the scientific and social trajectory of an institution, we intend to present the fundamental components that make up the Placental Histotherapy Center as well as to encourage new generations to continue the research work carried out in this center and the need to preserve its history. Material and Methods: A historical and bibliographical investigation of the documents preserved in the Library of the Center was carried out to base this article. Development: The essential aspects that support the history of the Center as well as the scientific, social and human involvement of Dr. Carlos Manuel Miyares Cao in this process are included. Conclusions: Our objective is to offer the entire trajectory of the Placental Histotherapy Center and its significance and importance for Cuban Science from a historical perspective as well as to inform specialists, doctors, and health workers in general about its outstanding work related to the recovery from serious diseases that afflict the world's population(AU)

Doctor Carlos Manuel Miyares Cao, paradigma de médico / Dr. Carlos Manuel Miyares Cao, an example of an outstanding doctor

José Martí sentenció: "Saberse sacrificar es el precio del éxito durable en todo", y con grandes sacrificios y éxitos en su vida laboral se resume la obra del Dr. Carlos Manuel Miyares Cao, un médico excepcional que supo vincular sus responsabilidades administrativas con la investigación y desarrollo, y la asistencia médica. Incansable luchador por los avances de la Medicina, gestor de la Escuela Cubana de Farmacología, representa un gran ejemplo para los médicos cubanos y de Latinoamérica. Durante su vida estudiantil, colaboró de forma destacada en las actividades que se desarrollaban en la época, siendo fundador de las milicias revolucionarias. Miyares Cao fue uno de los estudiantes de Medicina, fundador integrante de la Milicia Universitaria José Antonio Echeverría, quien con la simbólica camisa rojo vino, pantalón gris y boina negra, desfilaría el 27 de noviembre de 1959 desde la Universidad hasta la explanada de La Punta para rendir tributo a los 8 estudiantes de Medicina, y al decir de él, uno de sus más fraternales compañeros de estudios: ;lo recuerdo muy claro, alto, que por su estatura iba entre las filas finales, con su rifle y marchando con marcada disciplina, tal cual fue en su vida", con sus palabras reflejó los preceptos conceptuales que connotaron su existencia". El Dr. Miyares fue nombrado entre los primeros Instructores no graduados en la cátedra de Farmacología de la Facultad de Medicina de la Universidad de La Habana, tras la renuncia de los profesores universitarios. Asimismo, fundador de la AJR (Asociación Jóvenes Rebeldes) y Unión de Jóvenes Comunistas (UJC universitaria). Tuvo el privilegio de ser de los primeros egresados de la Revolución y su graduación, presidida, en el oriental Pico Turquino, por Fidel Castro, en 1965(AU)

José Martí said: "Knowing how to sacrifice is the price of lasting success for everything". The working life of Dr. Carlos Manuel Miyares Cao is summed up in great sacrifice and success. He was an outstanding doctor who knew how to link his administrative responsibilities to research and development and medical care. As a tireless fighter for the advances of medicine, he was the founder of the Cuban School of Pharmacology and a notable example for Cuban and Latin American doctors. During his student life, he collaborated with important activities that took place at his time, being founder of the revolutionary militias. During his medical studies, he was a founder member of the University Militias "José Antonio Echeverría". Wearing the symbolic red wine shirt, gray pants and black beret, he paraded on November 27, 1959 from the university to the Punta esplanade to pay tribute to the 8 medical students. One of his most fraternal fellow students says, "... I remember him very clearly; he was tall and because of his height he was among the ranks of the final lines; with his rifle he used to march with the discipline that characterized him during all his life." With his words, he illustrated the principles and convictions that marked his existence. After the resignation of university professors, Dr. Miyares was appointed among the first undergraduate Pharmacy instructors at the Department of Pharmacology of the School of Medicine of the University of Havana. He was also the founder of the AJR (Association of Young Rebels) and the UJC (Union of Young Communists) in the university. He had the privilege to be one of the first graduates after de triumph of the Revolution. His graduation, which was held at Pico Turquino in eastern Cuba, was presided by Fidel Castro in 1965(AU)

Effect of human placental extract on proliferation of human umbilical cord blood CD34(+) cells in vitro / 中国实验血液学杂志

The study was aimed to investigate the hematopoietic function of placenta tissue and clarify the effect of human placental chorionic tissue in different periods on proliferation of hematopoietic stem cells in vitro, in order to further understand the changes of the hematopoietic function of placenta with the time prolonging. The experiments were divided into four groups: early placenta (group B), mid-term placenta (group C), full-term placenta (group D), and blank group (group A). The hematopoietic stem cells were amplified in co-culture way, and the colony formation ability after the expansion was observed. The results showed that compared to initial concentration, the CD34(+) cells cultured with full-term placenta were amplified by (2.60 ± 0.20) times, which was significantly higher than those CD34(+) cells cultured with mid-term placenta (1.74 ± 0.24) and early placenta (1.14 ± 0.12), but that in blank group was reduced without amplification. After culture for 14 days, the colony number of group C and group D were significantly higher than that of group A and group B. Among them the number of CFU-GM, CFU-GEMM, BFU-E of group C all were a little higher than that of group D. It is concluded that human placental extract in different period without any exogenous cell factors all can support the proliferation of hematopoietic stem cells, this ability is getting stronger with time increasing. The colony formation ability of the amplified cells shows weakened after the first increase, this colony formation ability of the amplified cells in group C is strongest, slightly stronger than that of group D.

Efectividad de un extracto de placenta humana con Calcio (Melagenina Plus) en el tratamiento del vitiligo / Effectiveness of a human placental extract with calcium (Melagenina Plus) for the treatment of vitiligo

Introducción: Extractos alcohólicos de placenta humana han demostrado que poseen acción sobre la melanogénesis y sobre la proliferación de los melanocitos. Tales extractos producen un incremento en la densidad de los melanocitos así como de los gránulos de melanina cuando son aplicados tópicamente sobre las orejas y colas de ratones negros. Objetivo: Evaluar la acción de un extracto alcohólico de placenta humana con calcio (Melagenina Plus) en el tratamiento del Vitiligo, por ser esta una enfermedad en la que se pierden los melanocitos y por ende el pigmento melánico. Material y Método: Se realizó un estudio retrospectivo con 300 pacientes de vitiligo cubanos que fueron seleccionados por haber realizado de forma correcta la aplicación del extracto alcohólico de placenta humana con calcio sobre sus áreas despigmentadas. La selección se realizó con pacientes que se incorporaron al tratamiento con Melagenina Plus en los Servicios Clínicos del Centro de Histoterapia Placentaria entre los años 1998 hasta el 2003. Resultados: Al final del estudio 231 pacientes mostraron repigmentación completa o notable, 28 repigmentación parcial, 24 ninguna repigmentación y 17 nuevas lesiones. Conclusiones: Nuestros resultados demuestran que el extracto alcohólico de placenta con adición de calcio puede ser un eficaz e inocuo tratamiento del Vitiligo.

Introduction: Human placental alcohol extract have been successfully used on melanogenesis and melanocyte proliferation. Such extracts cause an increase in the number of melanocytes and melanin granules when applied topically on the ears and tails of black mice. Objectives: Assessment of the effectiveness of a human placental alcohol extract with calcium (Melagenina Plus) for the treatment of vitiligo, since this disease is characterized by melanocyte loss and consequently of melanine pigment. Material and methods: A retrospective study was carried out with 300 cuban vitiligo patients which were chosen because of their correct application on their depigmented areas of the human placental alcohol extract with calcium. Patients selection was made among those involved in the treatment with Melagenina Plus from the Clinical Service of the Placental Histotherapy Center since 1998 to 2003. Results: At the end of the study, 231 patients showed total or marked repigmentation, 28 moderate repigmentation, 24 no repigmentation and 17 new lesions. Conclusions: Results demonstrate that placental alcohol extracts with calcium added can be very effective and innocuous for the vitiligo treatment.

A comparative study of injection placentrex and conventional therapy in treatment of pelvic inflammatory disease.

To compare the effect of placentrex injection given along with conventional therapy, with conventional treatment alone on the symptoms and signs of pelvic inflammatory disease (PID) ie, abdominal pain, dysmenorrhoea and adnexal tenderness, 50 out of 100 women with PID were randomly assigned to receive intramuscular placentrex injection along with two-week conventional therapy and 50 received conventional treatment only. Abdominal pain, dysmenorrhoea and adnexal tenderness were evaluated at the end of 2 months. There was marked reduction in the sign of adnexal tenderness in the placentrex group as compared to conventional treatment group (p < 0.001). Subjective symptoms of lower abdominal pain and dysmenorrhoea were also relieved better in placentrex group (p < 0.01 and 0.05 respectively). This study showed significant and persistent improvement of signs and symptoms of PID in women who received injection placentrex.

Comparative evaluation of human placental extract for its healing potential in surgical wounds after orthopaedic surgery: an open, randomised, comparative study.

The study was conducted to compare the efficacy and safety of topical application of purified extract of human placenta (placentrex gel) versus povidone iodine for its wound healing potential after orthopaedic surgeries. In this open, comparative, randomised study, 79 patients above 18 years of age undergoing elective clean and uncontaminated orthopaedic surgery (open fracture reduction, spine surgery and debridement of wound) were enrolled in the study after obtaining written informed consent. Enrolled patients were randomised as per the PC generated randomisation chart (Rando 1.2, 2004) to receive either topical application of human placenta purified extract (PE) on the surgical wound or topical application of povidone iodine (PI) ointment on the surgical wound. Both preparations were applied topically on the surgical wound after the surgery, on days 3, 7 and on day 10, if required. Assessment of surgical wound was done after recovery from anaesthesia and on days 3, 7 and 10 based upon wound healing, physicians' global assessment of response to therapy (PGART) scale, pain and adverse effects. All 79 patients (40 PE and 39 PI) completed the study on day 10 as per the study protocol. Healing of the wound was observed in all patients. The number of patients reporting pain on days 3, 7 and 10 were similar in both PE and PI treatment (p, 0.527) groups. Wound induration was observed in 6 patients (15.00%) of PE and 15 (38.46%) of PI on day 7 (p, 0.041). None of the patients reported any side/adverse events during the study period. Purified placental extract and povidone iodine have comparative wound healing effects.

Cell adhesion by aqueous extract of human placenta used as wound healer.

Aqueous extract of human placenta, used as wound healer, has shown significant cell adhesion property on mouse peritoneal macrophages and P388D1 cultured macrophage cell line. This property was offered primarily by fibronectin type III like peptide present in the extract and is comparable to fibronectin on a molar basis. The peptide induce adhesion of cell through cell surface receptors having K(d) = 2.8 +/- 0.9 x 10(-5) M suggesting weak binding. This is in support of integrins receptors that typically exhibit low affinities. Cell adhesion was partially inhibited by Arg-Gly-Asp (RGD) peptide, anti-beta1 integrin suggesting that integrin beta1 receptors have roles to play in the process.

Neutrophilic Eccrine Hidradenitis Probably Induced by Intravenous Administration of Placental Extracts / 대한피부과학회지

Neutrophilic eccrine hidradenitis (NEH) is a rare, self-limited, neutrophilic dermatosis characterized histologically by a neutrophilic infiltration around the eccrine coils and necrosis of the eccrine glands. It occurs most commonly in patients undergoing chemotherapy for acute myelogenous leukemia and other malignant disease, but, other associations, such as infections, drugs or even in generally healthy individuals. We report a case of 45-year-old Korean woman with numerous erythematous papules on her trunk after treatment with intravenous administration of placental extracts. The hisopathological findings were compatible with neutrophilic eccrine hidradenitis.

Estudio del potencial hemolítico de la loción de melagenina plus por un método alternativo / Study about melagenin plus lotion hemolytic potential for an alternative method

En el presente estudio fue ensayado el test de hemólisis en sangre humana con el objetivo de comprobar el efecto hemolítico de la loción de melagenina Plus y compararlo con los resultados obtenidos en la evaluación de la irritabilidad oftálmica por el método de Draize. El test de hemolisis para la evaluación del potencial hemolítico, implica el empleo de muestras de sangre evitando el sacrificio o sufrimiento de los animales de experimentación sometidos a un ensayo de Draize. A partir de una solución de producto de ensayo de 0.03 por cientose obtuvieron diferentes diluciones que fueron probadas frente a una suspensión de eritrocitos ajustados por hemolisis total en agua destilada y posterior lectura de la absorbancia a 54 0nm, después de una hora de incubación. Los resultados arrojaron una concentración hemolítica 50 del producto (CH50) de 0,00315 por ciento

Human placental lipid induces mitogenesis and melanogenesis in B16F10 melanoma cells.

A hydroalcoholic extract of fresh term human placenta was found to be mitogenic as well as melanogenic on B16F10 mouse melanoma in an in vitro culture. The extract, a reservoir of a large number of bioactive molecules, was resolved to get the lipid fraction. Its activity was evaluated on B16F10 mouse melanoma by assessing the change in cellular morphology, growth and melanin induction. The lipid fraction, placental total lipid fraction (PTLF) tested in the study employed doses of 0 01 to 200 microg/ml; optimum growth and melanization accompanied by morphological changes were recorded at 10 and 100 microg/ml respectively. At intermediate doses growth and melanization were found to show a pattern of change over between growth and melanization and finally reached at an inverse relation at the respective optimal dose of response. Compared with defined sphingolipids, C(2) ceramide and sphingosine-1-phosphate, the results were mostly corroborative. The duality of biological response of sphingolipids as reported in numerous studies was comparable for the PTLF suggesting that its active component is a sphingolipid and showing its use for pigment recovery in vitiligo.

Avaliação em pacientes com vitiligo tratados com extrato hidroalcoólico de placenta humana a 50 por cento / Evaluation in vitiligo patients treated with 50 por cent human placenta hydroalcoholic extract

Durante os anos de 1968 a 1970 o Dr. Carlos Miyares Cao introduziu o extrato hidroalcoólico de placenta humana a 50 por cento no tratamento de vitiligo. Melagenina é o nome comercial desse extrato, que contém um celulotrofina identificada como lipoproteína de baixo peso molecular, que estimula a reprodução dos melanócitos e sua capacidade de produzir melanina. Objetivos: demonstrar os resultados obtidos no tratamento de vitiligo com melagenina em clínica privada, em estudo retrospectivo, não comparativo, entre 1992 e 1996. Foram estudados 206 pacientes que realizaram tratamento tópico com melagenina, em período de 6 a 12 meses. Foram avaliados seus dados demográficos, o tipo de vitiligo, o tempo de existência, a localização da primeira lesão, os antecedentes pessoais e familiares, os fatores desencadeantes, a superfície cutânea despigmentada, a evolução das lesões e sua repigmentação mediante anamnese, exame dermatológico e acompanhamento iconográfico. Empregaram-se como testes estatísticos prova de Friedman, teste de Wann-Whitney, análise de variância, teste qui-quadrado e teste de Kruskall-Wallis. Resultados: a repigmentação apresentou resultados favoráveis nos três tipos clínicos de vitiligo, com 87 por cento de repigmentação boa ou ótima aos 12 meses de avaliação do vitiligo segmentar e 72 por cento do tipo vulgar. O grupo com vitiligo universal foi muito pequeno, não permitindo comparação estatística adequada. O tratamento do vitiligo, com extrato hidroalcoólico de placenta humana a 50 por cento é boa alternativa

Empleo de placas filtrantes cubanas en el proceso de producción de melagenina loción / Use of Cuban filtrating platessin in the production process of melagenine lotion

La melagenina loción es un medicamento extraído de la placenta humana e identificado como una lipoproteína de bajo peso molecular, que ha demostrado su eficacia en la cura del vitiligo. Durante el proceso productivo de obtención de dicho extracto se emplea un sistema de placas de celulosa en la estación de filtración del Centro de Histoterapia Placentaria, Planta. El presente trabajo tiene como objetivo el empleo y evaluación de placas de producción nacional modelo Filtec 00 producidas en la Unión Investigación Producción Cuba 9 para la obtención del producto, para ello se evaluó el filtro teniendo en cuenta algunos criterios de operación además de los parámetros de control de la calidad del medicamento

Molecular Characterisation of a Putative Endogenous Retrovirus cDNA Isolated from Human Placental Tissue

The human genome comprises of abundant DNA sequences related to endogenous retroviruses (ERV) and a variety of solitary long terminal repeats (LTRs). Substantial numbers of intact retroviral particles have been detected by electron microscopy in normal human placental villous tissue particularly in syncytiotrophoblast. Understanding the molecular structure; organisation and distribution of these ERV sequences may lead to elucidation of their possible dual function at the foetal-maternal interface; proliferation and differentiation of cytotrophoblast and induction of local pregnancy-associated immune suppression thus allowing survival of the foetal allograft. In this study; antibody probes were used to screen a human placental expression library and cDNA clones isolated were characterized by polymerase chain reaction; Southern blot hybridisation; DNA cloning and partial nucleotide sequencing. A specific 1.7kb-cDNA clone was isolated from a human placental expression library. Further characterisation showed this clone represents a single copy gene; approximately 9-10kb and did not hybridise to the env region of ERV3 human endogenous retrovirus. The 1.7kb-cDNA clone may represent a provirus co-expressed with cellular sequences

Partial characterization of folate uptake in microvillous membrane vesicles isolated from human placenta

The purpose of the present study was to determine biochemical parameters of folate uptake, and the putative contribution of the membrane-anchored folate receptor in microvillous membrane vesicles obtained from the syncytiotrophoblast of human term placenta. Uptake of [3H]-pteroylglutamic acid (PGA) by microvillous membrane vesicles was pH dependent with a maximum at pH 6.0, and attained equilibrium at 60 min of incubation. Uptake was higher in the presence of an inward pH gradient (pHout = 6.0; pHin = 7.5) than in the absence of the gradient (pHout = pHin = 6.0). The effect of changes in medium osmolality showed that both binding to the vesicular membrane and internalization contributed to the measured [3H]-PGA uptake. Equilibrium uptake experiments using [3H]-PGA concentrations within the physiological range of folate in blood serum showed that saturation was achieved at 30 nM and revealed a single class of binding sites with a Kd of 1.8 nM for [3H]-PGA. Cleavage of the glycosyl-phosphatidylinositol moiety of the folate receptor, which anchors the receptor to the membrane, with phosphatidylinositolspecific phospholipase C resulted in a reduction of about 80 per cent in [3H]-PGA uptake. In conclusion, our results showed that the folate uptake in the maternally facing membrane of the human placenta presents a saturable component and is mediated by the folate receptor to ensure an adequate maternal-fetal folate transfer.

Acne polimorfo: Tratamiento con implacen / Polymorphic acbe: Treatment with implance

Se realiza el estudio de 40 pacientes con acne polimorfo, los que fueron atendidos en la Consulta de Dermatologia del Hospital Provincial Clinicoquirurgico Docente "Celia Sanchez Manduley", en el periodo comprendidode enero de 1988 a diciembre de 1989. Se revisa la literatura medica sobre los diversos metodos y medicamentos utilizados en la terapeutica de esta dermatosis. Se describe el esquema de tratamiento empleado con implacen en 30 pacientes; los10 restantes se trataron con placebo; se compara dicho esquema con los tradicionales y se observan mejores resultados con nuestro estudio. Se destaca la ausencia de recaidas, asi como el resultado del tratamiento de acuerdo con el sexo

Role of human placental extract on succinic dehydrogenase activity in carrageenin-induced edema in rats in vivo and its effect on erythrocyte lysis, platelet aggregation and trypsin activity in vitro.

Significant increase of liver succinic dehydrogenase (SDH, EC 1.3.99.1) activity was produced by carrageenin-induced edema in rats. Pretreatment with human placental extract inhibited the increased liver SDH activity in a dose-dependent manner. Placental extract was found to have little or no effect on the liver SDH activity in normal rats. Furthermore, heat-induced erythrocyte lysis was inhibited to a substantial extent by the extract and was found to be dose-responsive. However, adenosine diphosphate (ADP)-induced platelet aggregation and trypsin activity were not changed by the placental extract in vitro. The study indicates that the membrane stabilization and depletion of adenosine triphosphate (ATP) synthesis may contribute to antiinflammatory effect of the extract.